Delineation techniques of tumor hypoxia volume with 18F-FMISO PET imaging

被引:0
|
作者
Abdo, Redha-alla [1 ]
Lamare, Frederic [2 ]
Allard, Michele [2 ]
Fernandez, Philippe [2 ]
Bentourkia, M'hamed [1 ]
机构
[1] Univ Sherbrooke, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada
[2] Univ Bordeaux 2, Serv Med Nucl, EPHE, Bordeaux, France
关键词
D O I
暂无
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
18F-fluoromisonidazole (18F-FMISO) is the most extensively used Positron Emission Tomography (PET) hypoxia biomarker. Uptake of 18F-FMISO by tumors provides a quantitative map of hypoxia, which can be used for dose escalation in radiotherapy. Several techniques have been developed to quantify and delineate the tumor hypoxia volumes such as tumor-to-blood ratio (TBR), tumor-to-normal tissue ratio (TNR) and compartmental modeling approaches. This study aims to report quantitative analyzes aiming at delineating hypoxia in tumors. Scanning protocols involved a 15 or 30 min dynamic scan followed by 10 min static scan at 2 h, 3 h and 4 h in order to allow accumulation of 18F-FMISO in the tumors. The quantitative analyzes were performed with spectral analysis (SA) and also with different threshold levels of TBR and TNR. TBR and TNR images were obtained by normalizing the measured images with respect to the concentration of 18F-FMISO in blood and in normal tissue, respectively, with multiple threshold levels of 1.2, 1.4, 2 and 2.5. A similarity index (SI) approach was chosen to quantitatively compare the TBR, TNR and SA images. The results showed that the TBR technique produced less spatially constrained volumes around the tumor than TNR with the same threshold level. TBR was found to be more dependent on the accuracy of the concentration in blood. SA images show the decomposed components of tumor as accumulative regions in the center of the tumor while the perfused regions were seen on the peripheries. The hypoxia defined with SA was more accurate since it is not sensitive to input function artefacts such as the partial volume effect. We found some similarities at specific thresholding levels and imaging times between TBR and TNR. In one subject, at 3 h, TBR at a levels of 1.4, 2 and 2.5 were respectively close to TNR at 1.4, 1.4 and 2, and TNR at 2 h and 3 h with a level of 1.2 presented a high similarity (SI > 85%). Despite these similarities, more interventions are expected for proper decisions on hypoxia localisation.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] 18F-FMISO PET imaging: insights over MRI in patients with glioma
    Laudicella Riccardo
    Quartuccio Natale
    Alongi Pierpaolo
    Albano Domenico
    Gazzilli Maria
    Durmo Rexhep
    Bertagna Francesco
    Baldari Sergio
    Clinical and Translational Imaging, 2020, 8 : 3 - 10
  • [22] Commissioning of 18F-FMISO PET-CT circuit to determining the hypoxic tumor volume in lung cancer
    Jimenez, R.
    Becerra, N.
    Rodriguez, N.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S892 - S893
  • [23] Evaluation of tumor response to the antivascular agent DMXAA using 18F-FMISO PET
    Oehler-Janne, Christoph
    O'Donoghue, Joseph
    Ling, C. Clifton
    Carlin, Sean
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [24] Hypoxia imaging using 18F-FMISO PET/CT in predicting treatment response in patients with head and neck cancer
    Bhattacharya, Anish
    Meena, Ram
    Sood, Apurva
    Ghoshal, Sushmita
    Shukla, Jaya
    Mittal, Bhagwant
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [25] Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and 18F-FMISO PET
    Shiliang Huang
    Joel E. Michalek
    David A. Reardon
    Patrick Y. Wen
    John R. Floyd
    Peter T. Fox
    Geoffrey D. Clarke
    Paul A. Jerabek
    Kathleen M. Schmainda
    Mark Muzi
    Hyewon Hyun
    Eudocia Quant Lee
    Andrew J. Brenner
    Scientific Reports, 11
  • [26] Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and 18F-FMISO PET
    Huang, Shiliang
    Michalek, Joel E.
    Reardon, David A.
    Wen, Patrick Y.
    Floyd, John R.
    Fox, Peter T.
    Clarke, Geoffrey D.
    Jerabek, Paul A.
    Schmainda, Kathleen M.
    Muzi, Mark
    Hyun, Hyewon
    Lee, Eudocia Quant
    Brenner, Andrew J.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] Preliminary Results of 18F-FMISO PET in Evaluating Tumor Hypoxia and Predicting Response to Chemoradiation Therapy in Nasopharyngeal Carcinoma
    Ou, X.
    Cheng, J.
    Zhang, Y.
    Hu, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S486 - S486
  • [28] 18F-FMISO PET of an Intracranial Tuberculoma A Great Mimicker
    Sakata, Akihiko
    Fushimi, Yasutaka
    Arakawa, Yoshiki
    Shimizu, Yoichi
    Nakamoto, Yuji
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (04) : E212 - E213
  • [29] Correction to: 18F-FMISO PET imaging: insights over MRI in patients with glioma
    Riccardo Laudicella
    Natale Quartuccio
    Pierpaolo Alongi
    Domenico Albano
    Maria Gazzilli
    Rexhep Durmo
    Francesco Bertagna
    Sergio Baldari
    Clinical and Translational Imaging, 2020, 8 : 123 - 123
  • [30] Detection of Hypoxia With 18F-Fluoromisonidazole (18F-FMISO) PET/CT in Suspected or Proven Pancreatic Cancer
    Segard, Tatiana
    Robins, Peter D.
    Yusoff, Ian F.
    Ee, Hooi
    Morandeau, Laurence
    Campbell, Elaine M.
    Francis, Roslyn J.
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (01) : 1 - 6